Overall Rating
Stock is slightly underperforming.
Stock's dividend yield is above average.
This rating is directly related to the length and consistency of a company's dividend payouts.
Dividend payouts are consistent, but increases small.
Earnings estimates have been cut slightly.
Recent Headlines
- Johnson & Johnson Delivers Good Earnings, Raises Guidance (JNJ)
Tue, Oct 14, 2008 - Dividend Stock Recommendation Changes (WMI, KMP, KMR, JNJ, YPF)
Mon, Oct 13, 2008 - Earnings Season Kicks Off (INTC, JNJ, JPM, WFC, more)
Sun, Oct 12, 2008 - 20 Dividend Stocks Removed from Our Recommended List
Tue, Oct 7, 2008 - Potential Ban on Kids Cold Remedies May Affect Pharmaceutical Sector (JNJ, WYE, NVS, PG)
Thu, Oct 2, 2008 - Medtronic Beats Revenue Numbers, Misses EPS estimates (MDT)
Tue, Aug 19, 2008 - Johnson & Johnson Delivers on Their Quarter (JNJ)
Tue, Jul 15, 2008 - Steady Medical Dividend Play With Johnson & Johnson (JNJ)
Mon, Jul 14, 2008
Profile & Recommendation
Company Profile
Johnson&Johnson (JNJ)-diviersified Pharmaceutical company. The annual dividend has been increased for 45 consecutive years. Some of their brands include Aveeno, Band-Aid, Carefree, Motrin IB, Neutrogena, Pepcid Ac, Rembrandt, Splenda, Tylenol, Listerine, Nicorette, and Sudafed. The companys Medical Devices and Diagnostics segment provides suture and mechanical wound closure products, surgical equipment and devices, wound management and infection prevention products, interventional and diagnostic cardiology products, diagnostic equipment and supplies, joint replacements, and disposable contact lenses. The company was founded in 1885 and is based in New Brunswick, New Jersey.
Based on our rating criteria, this stock has achieved a "Neutral" rating. Stocks with a neutral rating are considered mediocre investments in terms of expected price growth and dividend payments.
Stock Notes
This large cap stock does not make an attractive dividend stock investment at this time.






Direct Competitors
RSS Feeds